|
76
|
257
|
6otpA |
Carbonic anhydrase ii complexed with ureic benzene sulfonamide mb10-586b |
|
79
|
257
|
6oukA |
Carbonic anhydrase ii complexed with benzene sulfonamide mb10-580b |
|
80
|
257
|
6otmA |
Carbonic anhydrase ix mimic complexed with ureic benzene sulfonamide mb10-586b |
|
77
|
257
|
6oumA |
Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb10-580b |
|
80
|
257
|
6otkA |
Carbonic anhydrase ix mimic complexed with ureido benzene sulfonamide mb10-596b |
|
75
|
257
|
6oueA |
Carbonic anhydrase ii complexed with benzene sulfonamide mb11-707a |
|
75
|
257
|
6otqA |
Carbonic anhydrase ii complexed with ureic benzene sulfonamide mb10-596b |
|
77
|
257
|
6oubA |
Carbonic anhydrase ii complexed with benzene sulfonamide mb11-694b |
|
76
|
258
|
6vj3A |
Carbonic anhydrase ii in complex with pyrimidine-based inhibitor |
|
80
|
257
|
6vkgA |
Human carbonic anhydrase ix mimic with epacadostat bound |
|
184
|
455
|
6nv8A |
Perdeuterated tyrosine phenol-lyase from citrobacter freundii complexed with an aminoacrylate intermediate formed from s-ethyl-l-cysteine and 4-hydroxypyridine |
|
174
|
455
|
6nv8B |
Perdeuterated tyrosine phenol-lyase from citrobacter freundii complexed with an aminoacrylate intermediate formed from s-ethyl-l-cysteine and 4-hydroxypyridine |
|
77
|
257
|
6u4qA |
Carbonic anhydrase 2 in complex with sb4197 |
|
78
|
257
|
6u4tA |
Carbonic anhydrase 9 in complex with sb4197 |
|
77
|
257
|
6nm0A |
Selective inhibition of carbonic anhydrase ix activity, using compound slc-149, displays limited anticancer effects in breast cancer cell lines |
|
78
|
257
|
6nlvA |
Selective inhibition of carbonic anhydrase ix activity, using compound slc-149, displays limited anticancer effects in breast cancer cell lines |
|
78
|
257
|
6ugzA |
Human carbonic anhydrase ix-mimic complexed with sb4-208 |
|
80
|
257
|
6uh0A |
Human carbonic anhydrase 2 in complex with sb4-202 |
|
78
|
257
|
6ugpA |
Human carbonic anhydrase 2 complexed with sb4-206 |
|
76
|
257
|
6ugoA |
Human carbonic anhydrase ix-mimic complexed with sb4-205 |
|
77
|
257
|
6ugrA |
Human carbonic anhydrase 2 complexed with sb4-208 |
|
73
|
257
|
6ugnA |
Human carbonic anhydrase 2 complexed with sb4-205 |
|
76
|
257
|
6ugqA |
Human carbonic anhydrase ix-mimic complexed with sb4-206 |
|
188
|
543
|
6uoiA |
Crystal structure of cytosolic fumarate hydratase from leishmania major in a complex with malonate |
|
185
|
541
|
6up9A |
Crystal structure of t467a variant of cytosolic fumarate hydratase from leishmania major in a complex with malonate |
|
185
|
543
|
6uojA |
Crystal structure of cytosolic fumarate hydratase from leishmania major in a complex with succinate |
|
169
|
438
|
6d3qA |
Crystal structure of escherichia coli enolase complexed with a natural inhibitor sf2312. |
|
89
|
260
|
6uapA |
Crystal structure of tryptophan synthase from m. tuberculosis - open form with brd6309 bound |
|
153
|
405
|
6uapB |
Crystal structure of tryptophan synthase from m. tuberculosis - open form with brd6309 bound |
|
156
|
404
|
6ub9B |
Crystal structure of tryptophan synthase from m. tuberculosis - aminoacrylate- and brd6309-bound form |
|
91
|
260
|
6ub9A |
Crystal structure of tryptophan synthase from m. tuberculosis - aminoacrylate- and brd6309-bound form |
|
76
|
259
|
6pgxA |
Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity |
|
102
|
268
|
6dzoA |
Crystal structure of salmonella typhimurium tryptophan synthase mutant beta-q114a with 2-({[4-(trifluoromethoxy)phenyl]sulfonyl}amino)ethyl dihydrogen phosphate (f9f) at the alpha-site, cesium ion at the metal coordination site, and [3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-serine (pls) at the beta-site. |
|
152
|
394
|
6dzoB |
Crystal structure of salmonella typhimurium tryptophan synthase mutant beta-q114a with 2-({[4-(trifluoromethoxy)phenyl]sulfonyl}amino)ethyl dihydrogen phosphate (f9f) at the alpha-site, cesium ion at the metal coordination site, and [3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-serine (pls) at the beta-site. |
|
76
|
257
|
6eeoA |
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines. |
|
76
|
257
|
6edaA |
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines. |
|
76
|
257
|
6ebeA |
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines. |
|
76
|
257
|
6eeaA |
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines. |
|
78
|
257
|
6eehA |
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines. |
|
184
|
540
|
6msoA |
Crystal structure of mitochondrial fumarate hydratase from leishmania major in a complex with inhibitor thiomalate |
|
160
|
395
|
6ducB |
Crystal structure of mutant beta-k167t tryptophan synthase in complex with inhibitor n-(4'-trifluoromethoxybenzenesulfonyl)-2-amino-1-ethylphosphate (f9f) at the alpha-site, cesium ion at the metal coordination site, and 2-aminophenol quinonoid (1d0) at the beta-site |
|
163
|
394
|
6d0vB |
Tryptophan synthase q114a mutant in complex with inhibitor n-(4'-trifluoromethoxybenzenesulfonyl)-2-amino-1-ethylphosphate (f9f) at the alpha-site, aminoacrylate (p1t) at the beta site, and cesium ion at the metal coordination site |
|
96
|
268
|
6ducA |
Crystal structure of mutant beta-k167t tryptophan synthase in complex with inhibitor n-(4'-trifluoromethoxybenzenesulfonyl)-2-amino-1-ethylphosphate (f9f) at the alpha-site, cesium ion at the metal coordination site, and 2-aminophenol quinonoid (1d0) at the beta-site |
|
130
|
304
|
5in8A |
Crystal structure of q151h aspergillus terreus aristolochene synthase |
|
78
|
258
|
6oe0A |
Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases ii and vii and show neuropathic pain attenuating effects |
|
77
|
258
|
6oe1A |
Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases ii and vii and show neuropathic pain attenuating effects |
|
77
|
259
|
6odzA |
Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases ii and vii and show neuropathic pain attenuating effects |
|
103
|
267
|
6d0vA |
Tryptophan synthase q114a mutant in complex with inhibitor n-(4'-trifluoromethoxybenzenesulfonyl)-2-amino-1-ethylphosphate (f9f) at the alpha-site, aminoacrylate (p1t) at the beta site, and cesium ion at the metal coordination site |
|
143
|
363
|
3tu9A |
Crystal structure of rabbit muscle aldolase bound with 5-o-methyl mannitol 1,6-phosphate |
|
77
|
258
|
3s9tA |
Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-5-{[(4,6-dimethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide |
